Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Merit Medical Systems (MMSI) EPS (Weighted Average and Diluted) (2016 - 2025)

Merit Medical Systems (MMSI) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with $0.64 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 39.13% to $0.64 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.13 through Dec 2025, up 4.93% year-over-year, with the annual reading at $2.13 for FY2025, 4.93% up from the prior year.
  • EPS (Weighted Average and Diluted) hit $0.64 in Q4 2025 for Merit Medical Systems, up from $0.46 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.64 in Q4 2025 to a low of $0.09 in Q2 2021.
  • Historically, EPS (Weighted Average and Diluted) has averaged $0.4 across 5 years, with a median of $0.45 in 2023.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): skyrocketed 520.0% in 2021 and later dropped 17.24% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.35 in 2021, then surged by 65.71% to $0.58 in 2022, then decreased by 17.24% to $0.48 in 2023, then dropped by 4.17% to $0.46 in 2024, then skyrocketed by 39.13% to $0.64 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for MMSI at $0.64 in Q4 2025, $0.46 in Q3 2025, and $0.54 in Q2 2025.